TuHURA Biosciences Draws $650K on $50M Revolving Credit Facility

What Happened

• TuHURA Biosciences announced it drew $650,000 on September 14, 2026 under a previously disclosed revolving Loan Agreement with Parkview Holdings One LLC.
• The Loan Agreement (entered April 21, 2026) provides up to $50 million in revolving availability and matures on April 21, 2031. The company said the new draw will be used for general corporate purposes. The full Loan Agreement was filed as an exhibit to the company’s April 22, 2026 Form 8‑K.

Key Details

• Lender: Parkview Holdings One LLC (affiliate of the company’s largest stockholder is noted as a potential conflict).
• Recent draw: $650,000 on September 14, 2026.
• Facility size and term: up to $50 million available; maturity April 21, 2031.
• Disclosure: Description of the Loan Agreement is qualified by the full agreement filed as Exhibit 4.1 to the April 22, 2026 Form 8‑K.

Why It Matters

• This draw increases TuHURA’s near-term liquidity, though the amount ($650K) is small relative to the $50M facility.
• Investors should note the lender relationship (an affiliate of a major shareholder) and the filing’s caution that future draws depend on satisfying agreement conditions and maintaining compliance.
• Monitor future SEC filings for additional draws, use of proceeds, and any updates on the company’s capital needs or covenant compliance.